ALONGI, FILIPPO
 Distribuzione geografica
Continente #
NA - Nord America 15.643
EU - Europa 7.843
AS - Asia 7.086
SA - Sud America 2.061
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 14
Totale 32.805
Nazione #
US - Stati Uniti d'America 15.448
SG - Singapore 2.637
DE - Germania 1.988
BR - Brasile 1.757
CN - Cina 1.737
PL - Polonia 1.467
UA - Ucraina 1.358
HK - Hong Kong 1.217
RU - Federazione Russa 914
GB - Regno Unito 779
VN - Vietnam 584
TR - Turchia 359
IT - Italia 354
IE - Irlanda 329
FI - Finlandia 261
AR - Argentina 115
SE - Svezia 113
IN - India 110
CA - Canada 95
BD - Bangladesh 85
ID - Indonesia 76
FR - Francia 70
MX - Messico 56
EC - Ecuador 52
IQ - Iraq 51
ZA - Sudafrica 42
AT - Austria 39
CO - Colombia 39
NL - Olanda 29
PK - Pakistan 29
SA - Arabia Saudita 29
BE - Belgio 28
MA - Marocco 26
ES - Italia 22
JP - Giappone 22
PY - Paraguay 21
VE - Venezuela 20
KE - Kenya 19
PE - Perù 19
UZ - Uzbekistan 19
CL - Cile 16
CZ - Repubblica Ceca 16
EU - Europa 15
IL - Israele 15
AU - Australia 13
BO - Bolivia 11
CH - Svizzera 11
GR - Grecia 11
JO - Giordania 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
EG - Egitto 10
JM - Giamaica 10
TW - Taiwan 10
KZ - Kazakistan 9
LT - Lituania 9
TT - Trinidad e Tobago 9
AZ - Azerbaigian 8
BH - Bahrain 8
CR - Costa Rica 8
DZ - Algeria 8
LB - Libano 8
UY - Uruguay 8
ET - Etiopia 7
PT - Portogallo 7
DO - Repubblica Dominicana 6
NP - Nepal 6
OM - Oman 6
KG - Kirghizistan 5
MU - Mauritius 5
AL - Albania 4
BG - Bulgaria 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
HN - Honduras 4
IR - Iran 4
KW - Kuwait 4
LA - Repubblica Popolare Democratica del Laos 4
PA - Panama 4
PH - Filippine 4
AM - Armenia 3
GY - Guiana 3
LV - Lettonia 3
MD - Moldavia 3
MY - Malesia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
HU - Ungheria 2
KH - Cambogia 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
RS - Serbia 2
TJ - Tagikistan 2
AO - Angola 1
Totale 32.788
Città #
Fairfield 2.569
Warsaw 1.463
Ashburn 1.320
Woodbridge 1.210
Hong Kong 1.207
Singapore 1.176
Jacksonville 1.066
Seattle 960
Cambridge 926
Houston 893
Wilmington 834
Princeton 611
Dallas 570
Chandler 564
Beijing 444
Ann Arbor 411
Dublin 321
Istanbul 295
New York 288
Nanjing 235
Helsinki 212
Los Angeles 206
Ho Chi Minh City 192
Des Moines 169
The Dalles 166
Moscow 147
Dearborn 136
Redondo Beach 130
San Diego 124
Buffalo 114
São Paulo 114
Hanoi 107
Nürnberg 100
London 89
Nanchang 89
Changsha 83
Dong Ket 74
Chicago 59
Munich 56
Jinan 55
Hebei 53
Jiaxing 51
Rio de Janeiro 51
Shanghai 47
Shenyang 45
Brescia 41
Nuremberg 39
San Francisco 39
Brasília 38
Brooklyn 36
Tianjin 35
Belo Horizonte 34
Curitiba 33
Boardman 32
Phoenix 31
Jakarta 30
Orange 29
Kocaeli 28
Kunming 27
Montreal 27
Brussels 26
Kilburn 26
Frankfurt am Main 25
North York 25
Westminster 25
Johannesburg 24
Santa Clara 24
Lappeenranta 23
Romola 23
Hangzhou 22
Milan 22
Poplar 22
Fortaleza 21
Guangzhou 21
Porto Alegre 21
Salt Lake City 21
Haiphong 20
Kyiv 20
Turku 20
Zhengzhou 20
Denver 19
Dhaka 19
Salvador 19
Tokyo 19
Goiânia 18
Guayaquil 18
Manaus 18
Nairobi 18
Santo André 18
Tashkent 18
Vienna 18
Ankara 17
Da Nang 17
Ribeirão Preto 17
Rome 17
Toronto 17
Quito 16
West Jordan 16
Atlanta 15
Guarulhos 15
Totale 21.331
Nome #
1.5 T MR-guided and daily adapted SBRT for prostate cancer: Feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment 368
Weekly Cisplatin and Volumetric-Modulated Arc Therapy With Simultaneous Integrated Boost for Radical Treatment of Advanced Cervical Cancer in Elderly Patients: Feasibility and Clinical Preliminary Results 251
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: Role of local treatments 245
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: The point of view of the radiation oncologist 245
Dose-volumerelated dysphagia after constrictor muscles definition in head and neck cancer intensitymodulated radiation treatment 244
Postoperative breast radiotherapy after neoadjuvant chemotherapy: which uncertainties still remain? 240
SBRT and extreme hypofractionation: A new era in prostate cancer treatments? 240
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 Patients 239
Dose variability in different lymph node levels during locoregional breast cancer irradiation: the impact of deep-inspiration breath hold 231
Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique 226
Radiotherapy in patients with connective tissue diseases 225
1.5 T MR-Guided Daily Adapted SBRT on Lymph Node Oligometastases from Prostate Cancer 224
Real-time intra-fraction motion management in breast cancer radiotherapy: Analysis of 2028 treatment sessions 210
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 206
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 195
MR-guidance in clinical reality: Current treatment challenges and future perspectives 187
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study) 183
ONE SHOT - single shot radiotherapy for localized prostate cancer: Study protocol of a single arm, multicenter phase I/II trial 181
(Ga-68)-PSMA-PET/CT for the detection of postoperative prostate cancer recurrence: Possible implications on treatment volumes for radiation therapy 179
In reply to Borras et al. the strengthening of Radiation Oncologist role inside multidisciplinary arena within 2025 176
Radiotherapy in patients with HIV: current issues and review of the literature 176
Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial 175
Image-guided radiation therapy (IGRT): practical recommendations of Italian Association of Radiation Oncology (AIRO) 172
Stereotactic body radiation therapy and intensity modulated radiation therapy induce different plasmatic cytokine changes in non-small cell lung cancer patients: a pilot study 168
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 165
An update on radiation therapy in head and neck cancers 164
Mastectomy or breast-conserving therapy for early breast cancer in real-life clinical practice: outcome comparison of 7565 cases 162
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 161
Role of radiosurgery/stereotactic radiotherapy in oligometastatic disease: Brain oligometastases 158
Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039. 157
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease. 156
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective 156
Intra-fraction and Inter-fraction analysis of a dedicated immobilization device for intracranial radiation treatment 156
What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review 153
18F-sodium fluoride PET-CT for the assessment of brain metastasis from lung Adenocarcinoma 151
Reply to 'Comment on 'Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study'' 149
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system 149
A plethora of therapeutic opportunities for elderly patients with cancer: A nontrivial choice 145
Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer. 144
A single-center retrospective safety analysis of cyclin-dependent kinase 4/6 inhibitors concurrent with radiation therapy in metastatic breast cancer patients 144
[11C]choline-PET-guided helical tomotherapy and estramustine in a patient with pelvic-recurrent prostate cancer: local control and toxicity profile after 24 months 143
Two months of radiation oncology in the heart of Italian “red zone” during COVID-19 pandemic: paving a safe path over thin ice 143
Non-palliative radiotherapy in ab initio oligometastatic prostate cancer: an Italian national survey 141
11C choline PET guided salvage radiotherapy with volumetric modulation arc therapy and hypofractionation for recurrent prostate cancer after HIFU failure: preliminary results of tolerability and acute toxicity 141
Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer 140
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 138
Stereotactic precision and conventional radiotherapy evaluation (SPACE)-Trial for medically inoperable Stage I NSCLC: A lost opportunity? 138
Extreme hypofractionation for early prostate cancer: Biology meets technology 137
Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology 137
Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature 136
Stage-I small cell lung cancer: A new potential option for stereotactic ablative radiation therapy? A review of literature. 136
Technical Note: Correction for intra-chamber dose gradients in reference dosimetry of flattening-filter-free MV photon beams 135
Radiation dose-response relationship for risk of coronary heart disease in survivors of hodgkin lymphoma 135
Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study. 134
Watch-and-wait versus surgical resection for patients with rectal cancer 134
Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis 134
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 133
From radiobiology to technology: What is changing in radiotherapy for prostate cancer 133
Choline-PET in prostate cancer management: The point of view of the radiation oncologist 132
Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: Is it an underestimated phenomenon A radiation oncologist's perspective 132
Stereotactic radiosurgery for patients with brain metastases 131
Prostate cancer as a paradigm of multidisciplinary approach? highlights from the italian young radiation oncologist meeting 131
Cancer Therapy combining high-intensity focused ultrasound and megavoltage radiation 131
GUROPA survey: genito-urinary radiation oncology prescription attitudes 131
Personalized - Not omitted - Radiation oncology for breast cancer 131
Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy 130
Cone-beam computed tomography in lung stereotactic ablative radiation therapy: Predictive parameters of early response 130
Optical Surface Scanning for Patient Positioning in Radiation Therapy: A Prospective Analysis of 1902 Fractions 130
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 129
Organ sparing and clinical outcome with step-and-shoot IMRT for head and neck cancer: a mono-institutional experience 128
Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies 128
Neuroendocrine carcinoma of the breast: Current evidence and future perspectives 127
Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis 127
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: Dosimetric impact of an increased near-maximum target dose and of a rectal spacer 127
Crowd knowledge based community in radiotherapy: In response to Yartev et al 126
Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study 126
Stereotactic body radiotherapy for lung oligometastases impacts on systemic treatment-free survival: a cohort study 126
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 126
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 126
The STYRO 2011 project: a survey on perceived quality of training among young Italian radiation oncologists. 125
Toxicity of stereotactic body radiation therapy versus intensity-modulated radiation therapy for prostate cancer: A potential comparison bias 125
Stereotactic body radiotherapy with flattening filter-free beams for prostate cancer: assessment of patient-reported quality of life 125
Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity 125
Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost 125
The BUONGIORNO project: Burnout syndrome among young italian radiation oncologists 125
Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal? 125
Consolidative local therapy in oligometastatic patients 123
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 123
Stereotactic radiosurgery for intracranial metastases: Linac-based and gamma-dedicated unit approach 123
Hypofractionated radiotherapy in pancreatic cancer: Lessons from the past in the era of stereotactic body radiation therapy 122
Impact of surface-guided positioning on the use of portal imaging and initial set-up duration in breast cancer patients 122
Could single-high-dose radiotherapy be considered the new frontier of stereotactic ablative radiation therapy? 121
Impact of 18F-choline PET/CT in the decision-making strategy of treatment volumes in definitive prostate cancer volumetric modulated radiation therapy 120
Regarding Ening et al. Charlson comorbidity index: an additional prognostic parameter for preoperative glioblastoma patient stratification 120
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 120
Stability and reproducibility of 6013 deep inspiration breath-holds in left-sided breast cancer 120
Sequential boost in neoadjuvant irradiation for T3N0-1 rectal cancer: Long-term results from a single-center experience 120
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial. 119
Comorbidities and intensity-modulated radiotherapy with simultaneous integrated boost in elderly breast cancer patients 119
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 119
Totale 15.395
Categoria #
all - tutte 179.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 179.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.421 0 0 0 0 0 605 290 682 408 720 376 340
2021/20222.185 164 407 63 144 18 155 121 215 117 201 158 422
2022/20231.840 359 34 46 145 125 501 6 182 263 25 73 81
2023/20242.079 121 56 120 165 84 300 65 65 622 56 41 384
2024/20254.931 21 29 50 567 658 373 385 183 583 483 1.019 580
2025/20266.268 860 1.491 1.408 1.724 648 137 0 0 0 0 0 0
Totale 33.281